Mirati Therapeutics, Inc. (MRTX): Price and Financial Metrics


Mirati Therapeutics, Inc. (MRTX)

Today's Latest Price: $90.41 USD

0.55 (0.61%)

Updated Jan 28 6:55pm

Add MRTX to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 339 in Biotech

See all "A" rated Strong Buy stocks

MRTX Stock Summary

  • The ratio of debt to operating expenses for Mirati Therapeutics Inc is higher than it is for about only 0.37% of US stocks.
  • MRTX's price/sales ratio is 616.84; that's higher than the P/S ratio of 99.44% of US stocks.
  • Revenue growth over the past 12 months for Mirati Therapeutics Inc comes in at -33.79%, a number that bests merely 5.68% of the US stocks we're tracking.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Mirati Therapeutics Inc are RARX, FIXX, QURE, TOCA, and CRNX.
  • MRTX's SEC filings can be seen here. And to visit Mirati Therapeutics Inc's official web site, go to www.mirati.com.
MRTX Daily Price Range
MRTX 52-Week Price Range

MRTX Stock Price Chart More Charts


MRTX Price/Volume Stats

Current price $90.41 52-week high $132.59
Prev. close $89.86 52-week low $55.11
Day low $88.07 Volume 346,900
Day high $92.73 Avg. volume 845,772
50-day MA $104.67 Dividend yield N/A
200-day MA $91.09 Market Cap 3.57B

Mirati Therapeutics, Inc. (MRTX) Company Bio


Mirati Therapeutics develops molecularly targeted cancer treatments that are intended to inhibit tumor growth. The company was founded in 1995 and is based in San Diego, California.





MRTX Latest News Stream


Event/Time News Detail
Loading, please wait...

MRTX Latest Social Stream


Loading social stream, please wait...

View Full MRTX Social Stream

MRTX Price Returns

1-mo -29.60%
3-mo -4.00%
6-mo -7.82%
1-year 45.47%
3-year 1,558.90%
5-year 335.71%
YTD -29.84%
2019 203.77%
2018 132.44%
2017 284.21%
2016 -84.97%
2015 70.63%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.6211 seconds.